Balaji Amines announces 38th AGM on July 10, 2026
Balaji Amines Limited has scheduled its 38th Annual General Meeting for July 10, 2026, via video conferencing, and published the notice in newspapers on June 17, 2026. The company reported a strong financial performance for FY26, with consolidated revenue increasing to ₹1,454 crore and Profit After Tax reaching ₹169 crore. The Board recommended a dividend of ₹11 per share, subject to shareholder approval.

*this image is generated using AI for illustrative purposes only.
Balaji Amines Limited has submitted the newspaper publication details for its 38th Annual General Meeting (AGM), scheduled to be held on Friday, July 10, 2026, at 12:00 Noon IST through Video Conferencing (VC) or Other Audio Visual Means (OAVM). The notice was filed pursuant to Regulation 30 and Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The advertisements were published in The Indian Express (English) and Divya Marathi (Marathi) on June 17, 2026. The Annual Report for Financial Year 2025-26 has been made available on the company's website.
AGM Key Agenda Items
The 38th AGM will transact the following business:
- Adoption of Audited Financial Statements (Standalone and Consolidated) for the financial year ended March 31, 2026
- Declaration of dividend of ₹11 per equity share for FY 2025-26
- Re-appointment of Mr. Ande Srinivas Reddy (Whole-time Director), who retires by rotation
- Ratification of remuneration of ₹75,000/- (plus GST and out-of-pocket expenses) payable to Mr. Narayan D. Dontul, Cost Auditors, for FY 2026-27
The Register of Members and Transfer Books will remain closed from Saturday, July 4, 2026 to Friday, July 10, 2026 (both days inclusive). Remote e-voting will be facilitated by NSDL, with the voting period commencing on Tuesday, July 7, 2026 at 9:00 A.M. and closing on Thursday, July 9, 2026 at 5:00 P.M. The record date (cut-off date) for e-voting is Friday, July 3, 2026.
FY26 Financial Performance
The company reported a significant improvement in financial performance for FY 2025-26. The following table summarises the key financial results:
| Metric: | Standalone FY26 (₹ in Lakhs) | Standalone FY25 (₹ in Lakhs) | Consolidated FY26 (₹ in Lakhs) | Consolidated FY25 (₹ in Lakhs) |
|---|---|---|---|---|
| Total Income: | 1,31,956.64 | 1,29,637.68 | 1,45,378.74 | 1,43,028.76 |
| Profit Before Tax (PBT): | 22,740.40 | 20,896.70 | 23,249.02 | 21,321.94 |
| Profit After Tax (PAT): | 16,552.83 | 15,621.27 | 16,915.68 | 15,859.14 |
On a consolidated basis, full-year revenue stood at ₹1,454 crore and PAT came in at ₹169 crore. The fourth quarter of FY26 was described as the company's strongest in years, delivering revenue of ₹403 crore, EBITDA of ₹102 crore at a 25% margin, and PAT of ₹65 crore, up 62% year-on-year. The standalone entity remained entirely debt-free, with all BAL expansion projects funded from internal cash generation.
Key Financial Ratios (Consolidated)
The following table presents key consolidated financial ratios for FY26 and FY25:
| Key Ratio: | FY26 | FY25 | Change (%) |
|---|---|---|---|
| Current Ratio: | 4.07 | 7.26 | -44% |
| Debtors Turnover: | 4.59 | 4.70 | -2.35% |
| Inventory Turnover: | 5.47 | 4.98 | 9.79% |
| Debt-Equity Ratio: | 0.06 | 0.01 | 1,075.49% |
| Interest Coverage Ratio: | 44.29 | 58.66 | -24.49% |
| Operating Profit Margin (%): | 16.69 | 15.53 | 7.51% |
| Net Profit Margin (%): | 11.87 | 11.35 | 4.57% |
| Return on Net Worth (%): | 7.61 | 8.11 | -6.20% |
The increase in the Debt-Equity Ratio and the decline in the Current Ratio are attributed to new loans taken for expansion projects of Balaji Speciality Chemicals Limited (BSCL).
Segment-Wise Sales Performance (Standalone)
The following table presents standalone segment-wise sales data:
| Particulars: | Quantity FY26 (MT) | Amount FY26 (₹ in lakh) | Quantity FY25 (MT) | Amount FY25 (₹ in lakh) | Quantity Growth (%) |
|---|---|---|---|---|---|
| Aliphatic Amines: | 29,997 | 40,230.54 | 30,847 | 40,404 | -2.76 |
| Speciality Chemicals: | 42,334 | 59,803 | 39,363 | 58,192 | 7.55 |
| Derivatives of Amines: | 34,640 | 52,550 | 34,183 | 38,224 | 1.34 |
| Total: | 1,06,970 | 1,52,584 | 1,04,393 | 1,36,820 | 2.47 |
Operational Milestones and Expansion Pipeline
FY26 saw the commissioning of several key projects that strengthen Balaji Amines' position in India's import-substitution landscape:
- Electronic Grade DMC commissioned in May 2025 — Balaji Amines is the sole domestic manufacturer of this critical component for EV batteries
- MIPA plant commissioned in Q1 FY26, enabling domestic supply for customers previously reliant on imports
- 6 MW solar plant commenced generation in April 2025, with approximately 30% of manufacturing energy now sourced from solar
- Methylamines plant (88,000 TPA) — the largest in India, built on indigenous technology — completed its first full year of operations in FY26
The R&D pipeline includes the following projects at various stages of execution:
| Product / Project: | Scale | Status |
|---|---|---|
| Dimethyl Ether (DME): | 1,00,000 TPA | Commissioned Q1 FY27. India's first commercial-scale plant. |
| N-Methyl Morpholine (NMM): | ~5,000 TPA | Civil works complete. Commissioning FY27. |
| Acetonitrile (ACN) expansion: | 60 MT/day | Improved process. Greenfield at Unit III. FY27 target. |
| Iso Propyl Amines (MIPA/DIPA): | 20–21 MT/day | Reconfigured from existing Ethyl Amines facility. Operational. |
| BSCL — EDA derivatives (Unit I): | DETA, TETA, PIP, AEEA, AEP | Brownfield. Commissioning H1 FY27. |
| BSCL — HCN, NaCN, EDTA (Unit II): | ₹750 crore project | Greenfield, Chincholi. Commissioning Q4 FY27. |
Dividend and Subsidiary Update
The Board has recommended a dividend of ₹11 per equity share at 550% of the face value of ₹2/- each for FY 2025-26, subject to member approval at the AGM. This represents the seventh consecutive year of such dividend recommendation. The dividend, if approved, would involve a cash outflow of ₹3,564.11 Lakhs.
Balaji Speciality Chemicals Limited (BSCL), the company's only subsidiary in which it holds a 55% stake, reported a turnover of ₹15,241.43 Lakhs and a Profit after Tax of ₹434.87 Lakhs for the period ended March 31, 2026. BSCL is executing a ₹750 crore greenfield and expansion project at MIDC, Chincholi, Solapur, in a phased manner, for the manufacture of high-technology products including Hydrogen Cyanide, Sodium Cyanide, and EDTA/EDTA 2Na. The credit rating of the company was affirmed at "IND AA/Negative/IND A1+" by India Ratings and Research Private Limited during the year.
CSR and ESG Highlights
During FY26, Balaji Amines spent ₹3.24 crore (₹3,24,04,194) on CSR activities against an obligation of ₹4.93 crore, reaching 27,24,372 beneficiaries through 104 community programmes. Key focus areas included education, healthcare, water conservation, rural development, and environmental sustainability. The unspent amount of ₹1.70 Crores has been transferred to a separate "Unspent CSR Account" for utilisation towards ongoing projects within the prescribed timelines. Export revenue for FY26 stood at ₹185 crore, compared to ₹166 crore in FY25 and ₹194 crore in FY24, with exports accounting for 14.30% of consolidated revenue and Europe representing 36.76% of total export revenue.
Historical Stock Returns for Balaji Amines
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.65% | +3.68% | +29.50% | +102.34% | +54.76% | -15.72% |
How will the commissioning of the ₹750 crore greenfield BSCL project impact the company's leverage ratios given the recent rise in the Debt-Equity ratio?
With the DME plant set to be commissioned in Q1 FY27, what are the projected revenue contributions and margin expectations for India's first commercial-scale facility?
Will the current expansion pipeline be sufficient to sustain the 62% YoY PAT growth seen in Q4 FY26, or is a slowdown anticipated as new capacities ramp up?


































